Celgene (NASDAQ:CELG) reported Q1 2018 earnings this Morning, coming in at $2.05 per share, beating Wall Street’s estimates of $1.96 per Share. Revenue for the quarter came in at $3.54 billion beating analyst estimates of $3.47 billion Recent Insider Trading for Celgene (NASDAQ:CELG)
- On 3/12/2018 James J Loughlin, Director, sold 9,250 with an average share price of $92.01 per share and the total transaction amounting to $851,092.50.
- On 2/23/2018 Ernest Mario, Director, sold 13,370 with an average share price of $94.49 per share and the total transaction amounting to $1,263,331.30.
- On 2/20/2018 Gilla Kaplan, Director, sold 9,250 with an average share price of $94.83 per share and the total transaction amounting to $877,177.50.
- On 2/15/2018 Gilla Kaplan, Director, sold 9,250 with an average share price of $95.99 per share and the total transaction amounting to $887,907.50.
- On 2/8/2018 Mark J Alles, Insider, bought 3,260 with an average share price of $91.90 per share and the total transaction amounting to $299,594.00.
- On 9/25/2017 Terrie Curran, Insider, sold 1,727 with an average share price of $143.89 per share and the total transaction amounting to $248,498.03.
Dividend History for Celgene (NASDAQ:CELG)
Recent Trading for Celgene (NASDAQ:CELG) Shares of Celgene closed the previous trading session at 87.17 up +1.77 2.07% with shares trading hands.